STATISTICAL ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS IN CLINICAL STUDIES: EXPECTATIONS AND LIMITATIONS

被引：0

作者：

Gillissen, A. ^{[1
]}

Glaab, T. ^{[2
]}

Lewis, M. ^{[3
]}

Buhl, R. ^{[2
]}

Worth, H.

机构：

[1] Robert Koch Hosp, St George Med Ctr, Leipzig, Germany

[2] Univ Hosp, Dept Pulm, Mainz, Germany

[3] FISPE Epidemiol GmbH, Berlin, Germany

来源：

JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2009年 / 60卷

关键词：

chronic obstructive pulmonary disease; exacerbation; statistics; INHALED CORTICOSTEROIDS; LUNG-FUNCTION; FLUTICASONE PROPIONATE; COPD EXACERBATIONS; BETA-AGONISTS; MORTALITY; TIOTROPIUM; OUTCOMES; METAANALYSIS; SALMETEROL;

D O I：

暂无

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

Acute exacerbations of chronic obstructive pulmonary disease (COPD) occur more frequently with increasing COPD severity and are associated with increased morbidity, reduced quality of life, and increased risk of mortality. The prevention and assessment of exacerbations, as a clinically and therapeutically relevant parameter, is a central aspect of clinical COPD studies. The aim of this review is to identify pittfalls in the analysis of the parameter of exacerbation and to describe the criteria that need to be considered in the statistical analysis of exacerbation studies.

引用

页码：7 / 11

页数：5

共 50 条

[21] Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review
Hurst, John R.
Wedzicha, Jadwiga A.
BMC MEDICINE, 2009, 7
[22] Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis
Benjamin F. Hartley
Neil C. Barnes
Sally Lettis
Chris H. Compton
Alberto Papi
Paul Jones
Respiratory Research, 21
[23] Predictors of 1-Year Mortality at Hospital Admission for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Slenter, R. H. J.
Sprooten, R. T. M.
Kotz, D.
Wesseling, G.
Wouters, E. F. M.
Rohde, G. G. U.
RESPIRATION, 2013, 85 (01) : 15 - 26
[24] Exacerbations of chronic obstructive pulmonary disease
Celli, B. R.
Barnes, P. J.
EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (06) : 1224 - 1238
[25] Chronic obstructive pulmonary disease. Are the times changing?
Almagro, P.
Sangil, A.
Custardoy, J.
Roman Teran, C. San
Martin Escudero, J. C.
Diez-Manglano, J.
REVISTA CLINICA ESPANOLA, 2013, 213 (03): : 152 - 157
[26] International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
Calverley, Peter M. A.
Martinez, Fernando J.
Vestbo, Jorgen
Jenkins, Christine R.
Wise, Robert
Lipson, David A.
Cowans, Nicholas J.
Yates, Julie
Crim, Courtney
Celli, Bartolome R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (01) : 25 - 33
[27] Clinical and laboratory parameters in assessing the risk of exacerbations in chronic obstructive pulmonary disease
Kadushkin, A. G.
Shman, T. V.
Goncharik, A. V.
Germenchuk, I. A.
Kolb, A. V.
Taganovich, A. D.
TERAPEVTICHESKII ARKHIV, 2015, 87 (03) : 10 - 16
[28] Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations
Xiao, Wei
Chen, Yi-long
Du, Long-yi
Wu, Jiqiu
Wang, Zhang
Mao, Bing
Wen, Fu-qiang
Gibson, Peter Gerard
Mcdonald, Vanessa M.
Yu, Haopeng
Fu, Juan-juan
RESPIRATORY RESEARCH, 2024, 25 (01)
[29] Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations
Yoon, Sunyoung
Kim, Tae-Eun
Kim, Tae-Hyung
Na, Ju Ok
Shin, Kyeong-Cheol
Rhee, Chin Kook
Jung, Sung Soo
Choe, Kang-Hyeon
Yoo, Kwang Ha
JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (02)
[30] Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
Sethi, Sanjay
Jones, Paul W.
Theron, Marlize Schmitt
Miravitlles, Marc
Rubinstein, Ethan
Wedzicha, Jadwiga A.
Wilson, Robert
RESPIRATORY RESEARCH, 2010, 11

← 1 2 3 4 5 →